Go to Top

Tag Archives

Tag Archives: ENMD

EntreMed, Inc. (ENMD): Initiation of a Second Site for its ENMD-2076 Study

EntreMed, Inc. (ENMD) announced today the initiation of a second site for its Phase 2 study of ENMD-2076 in triple-negative breast cancer (TNBC). Kathy Miller, MD, Associate Professor at the Melvin and Bren Simon Cancer Center at Indiana University serves as the investigator for the study. Indiana University joins the University of Colorado Cancer Center …Read More